That precision advantage reduces the chance of measurement errors and is one of the practical reasons many dosing guides recommend it
Cost-wise, compounded semaglutide at $199-$299/month through Omzo is substantially less than FDA-approved Ozempic or Wegovy at retail prices exceeding $1,000/month
Weight loss is a significant consideration for both medications, especially given the obesity epidemic and its association with conditions like Type 2 Diabetes
Lilly states that retatrutide is not available for public use and is legally available only to participants in Lilly clinical trials
So after poking my nose around, I really cant find anything to support the claim that retatrutide is muscle sparing compared to other GLP-1 receptor agonists
Some large database analyses have suggested a modest increase in pancreatitis risk, particularly in the first few months after initiation, while others have found no association after adjusting for confounding factors such as obesity, gallbladder disease, and alcohol use
